580 related articles for article (PubMed ID: 25913035)
1. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
[TBL] [Abstract][Full Text] [Related]
2. Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors.
Valković T; Gačić V; Ivandić J; Petrov B; Dobrila-Dintinjana R; Dadić-Hero E; Načinović-Duletić A
Turk J Haematol; 2015 Sep; 32(3):234-42. PubMed ID: 26376590
[TBL] [Abstract][Full Text] [Related]
3. A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction.
Özen M; Yılmaz G; Coşkun B; Topçuoğlu P; Öztürk B; Gündüz M; Atilla E; Arslan Ö; Özcan M; Demirer T; İlhan O; Konuk N; Balık İ; Gürman G; Akan H
Turk J Haematol; 2016 Mar; 33(1):41-7. PubMed ID: 26376622
[TBL] [Abstract][Full Text] [Related]
4. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
[TBL] [Abstract][Full Text] [Related]
5. Febrile neutropenia in the tropics: a description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia.
Cortés JA; Cuervo S; Gómez CA; Bermúdez D; Martínez T; Arroyo P
Biomedica; 2013; 33(1):70-7. PubMed ID: 23715309
[TBL] [Abstract][Full Text] [Related]
6. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of imipenem 1.5 g daily in febrile patients with short duration neutropenia after chemotherapy for non-leukemic hematologic malignancies and solid tumors: personal experience and review of the literature.
Jourdan E; Defez C; Topart D; Richard B; Bellabas H; Fabbro-Peray P; Jourdan J; Sotto A
Leuk Lymphoma; 2003 Apr; 44(4):619-26. PubMed ID: 12769338
[TBL] [Abstract][Full Text] [Related]
9. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
[TBL] [Abstract][Full Text] [Related]
10. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
Akova M; Paesmans M; Calandra T; Viscoli C;
Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
[TBL] [Abstract][Full Text] [Related]
11. Infections of febrile neutropenic patients in malignant hematological diseases.
Rókusz L; Liptay L
Mil Med; 2003 May; 168(5):355-9. PubMed ID: 12775168
[TBL] [Abstract][Full Text] [Related]
12. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
Roongpoovapatr P; Suankratay C
J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
[TBL] [Abstract][Full Text] [Related]
13. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).
Boğa C; Bolaman Z; Çağırgan S; Karadoğan İ; Özcan MA; Özkalemkaş F; Saba R; Sönmez M; Şenol E; Akan H; Akova M
Turk J Haematol; 2015 Jun; 32(2):100-17. PubMed ID: 26316478
[TBL] [Abstract][Full Text] [Related]
15. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of febrile neutropenic attacks in a tertiary care medical center in Turkey.
Sacar S; Hacioglu SK; Keskin A; Turgut H
J Infect Dev Ctries; 2008 Oct; 2(5):359-63. PubMed ID: 19745503
[TBL] [Abstract][Full Text] [Related]
17. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
18. Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience.
Gedik H; Yildirmak MT; Simsek F; Aydin D; Demirel N; Yokus O; Arica D
Afr Health Sci; 2012 Sep; 12(3):390-4. PubMed ID: 23382758
[TBL] [Abstract][Full Text] [Related]
19. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
20. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
